================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of earliest event reported: April 22, 2003
WEST PHARMACEUTICAL SERVICES, INC.
(Exact name of registrant as specified in charter)
Pennsylvania 1-8036 23-1210010
(State of Incorporation) (Commission File Number) (I.R.S. Employer
Identification No.)
101 Gordon Drive, P.O. Box 645, Lionville, Pennsylvania 19341-0645
(Address of Principal Executive Offices) (Zip Code)
(610) 594-2900
(Registrant's telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
================================================================================
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits:
Exhibit # Description
99.1 West Pharmaceutical Services, Inc. Press Release,
dated April 22, 2003.
Item 9. Regulation FD Disclosure
The following information is furnished pursuant to Item 12,
"Disclosure of Results of Operations and Fiancial Condition."
On April 22, 2003 West Pharmaceutical Services, Inc. (the "Company")
issued a press release announcing the Company's first quarter
financial results for the quarter ended March 31, 2003. A copy of the
press release is attached hereto as Exhibit 99.1 and is incorporated
herein by reference.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
WEST PHARMACEUTICAL SERVICES, INC.
Date: April 22, 2003 By: /s/ Linda R. Altemus
-------------------------------
Linda R. Altemus
Vice President and
Chief Financial Officer
EXHIBIT INDEX
99.1 West Pharmaceutical Services, Inc. Press Release, dated April 22, 2003.